Capstan Therapeutics Stock
Capstan Therapeutics is developing in vivo RNA-based therapies for oncology, fibrosis, and inflammation-related diseases. Its platform utilizes targeted lipid nanoparticles for precise delivery and control of engineered cells, aiming to advance innovative treatments in these fields.
Founded: 2021
Management Team
| Laura Shawver Ph.D. President & Chief Executive Officer |
| Justin Thacker Chief Financial Officer |
| Priya Karmali Ph.D. Chief Technology Officer |
| Adrian Bot Ph.D. Founding Chief Scientific Officer, Executive Vice President of Research & Development |
| Haig Aghajanian Ph.D. Co-Founder & Vice President of Research |
| Ramin Farzaneh-Far MD Chief Medical Officer |
